The RSV vaccine was approved by the FDA July 17 and will be available this fall, along with two different vaccine options for adults who are 65 years old.
“As we head into respiratory virus season this fall, it’s important to use these new tools available to help prevent severe RSV illness,” Mandy Cohen, MD, CDC director said in a statement. “I encourage parents of infants to talk to their pediatricians about this new immunization and the importance of preventing severe RSV.”
Experts say uptake of the new RSV vaccines in addition to updated flu and COVID-19 boosters will be key to preventing another ‘tripledemic‘ event affecting hospital capacities this coming viral season.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.